Philip Morris International
PM · What the business does, what can go wrong, and how options sellers approach it
What it does
Philip Morris International sells nicotine products to adult consumers, mostly outside the United States. Its business has two broad sides. The first is traditional cigarettes, including Marlboro, one of the best-known cigarette brands in the world. The second is a set of smoke-free products: IQOS heated tobacco devices and the tobacco sticks used in them, ZYN nicotine pouches, and vapes.
The company was spun off from Altria in 2008.
How it makes money
PMI sells cigarettes, heated tobacco sticks and devices, and nicotine pouches through wholesalers, retailers and its own channels. Cigarettes remain a major source of profit. They carry strong pricing power, because loyal customers tend to accept regular price increases.
The company is working to shift more of its sales toward smoke-free products. Heated tobacco creates a recurring revenue stream, since users keep buying tobacco sticks after the initial device purchase. Nicotine pouches are also bought repeatedly.
Why investors own it
- A large, cash-generating business with global scale and well-known brands.
- A long record of paying dividends, which attracts income-focused investors.
- A transition story: investors who see smoke-free products replacing cigarettes over time may view PMI as an early leader in that shift.
What can go wrong
- Regulation: taxes, flavor bans, marketing limits, and product approval rules can change quickly and differ by country.
- Litigation and public-health pressure on tobacco companies.
- Smoking rates keep falling in many markets, so the smoke-free shift has to succeed.
- Currency swings: the company reports in U.S. dollars but earns in many currencies.
- Competition from other tobacco companies and from illicit or unregulated vapes.
- Some investors avoid tobacco for ethical reasons, which can limit demand for the shares.
What to watch
- Growth in smoke-free product volumes and their share of total sales
- Cigarette pricing and volume trends
- IQOS user growth and ZYN demand
- Regulatory decisions on heated tobacco, pouches, and flavors
- Currency effects on reported results
- Dividend announcements and free cash flow
Options income angle
Options on PM are generally liquid near the current share price. Implied volatility tends to rise around earnings and regulatory news, though it is often lower than for growth stocks.
One caution: a sharp surprise can cause losses larger than the premium collected, and short calls face early assignment risk near ex-dividend dates.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 6, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Philip Morris International reported net revenues of $40.6 billion for 2025 and diluted EPS of $7.26, up 60.6% from $4.52. Much of that jump comes from a very large 2024 charge not repeating. The business keeps moving from cigarettes to smoke-free products (SFPs), which the filing describes as the strategic priority. That shift depends on regulators, tax authorities and courts, and the filing says all three can move against it.
How the business did
- Net revenues rose $2.8 billion, or 7.3%. Excluding currency and acquisitions/divestitures, they rose 6.5%, driven by higher combustible tobacco pricing and higher SFP volume, despite lower cigarette volumes and unfavorable mix.
- Diluted EPS compares against a 2024 depressed by a non-cash impairment of $2,316 million (an accounting write-down of an asset's value) on the RBH equity investment, worth $1.49 per share. Operations added $0.85 per share in 2025.
- Several 2025 charges offset part of the gain: $241 million of pre-tax restructuring for ending cigarette production in two German factories, a $176 million Germany excise tax charge on TEREA consumables, a $146 million after-tax Wellness investment impairment, and a $94 million pre-tax loss on the expected sale of consumer accessories and other businesses.
- Amortization of intangibles was $1,003 million, up from $835 million in 2024. The increase includes the U.S. IQOS rights reacquired from Altria Group, Inc. in May 2024.
- The excerpt provided does not include the cash flow or capital return discussion.
Risks specific to this company
- Russia and Ukraine: Russia was around 9% of cigarette and heated tobacco unit shipment volume and around 6% of total net revenues. The filing says action against its Russian assets, including nationalization, cannot be predicted and could force material impairments.
- Regulation of SFPs: Regulators may restrict or ban SFPs, and World Health Organization and FCTC proposals could limit their availability. In the U.S., the FDA authorized two versions of IQOS and 20 varieties of ZYN, but the filing says continued authorization is not guaranteed, especially if youth use rises.
- ZYN supply concentration: One Kentucky facility supplies substantially all of the capacity for U.S. ZYN sales, so a prolonged shutdown there could limit sales.
- Taxes: The cigarette portfolio is weighted toward premium prices, which price-based tax systems can penalize. SFPs also enjoy lower tax rates in many places, and some jurisdictions are moving those rates toward cigarette levels.
- Litigation: Some tobacco claims range into the billions of U.S. dollars, and oral nicotine litigation in U.S. courts began as of March 2024. In Canada, a plan resolving tobacco claims became effective August 29, 2025, with an aggregate settlement of CAD 32.5 billion shared among RBH, ITL and JTIM.
- Dependence on subsidiaries: As a U.S. holding company, its main source of funds is distributions from non-U.S. subsidiaries. Currency controls in some countries could block those payments.
What management is watching
- SFP growth: Smoke-free products were available in 106 markets at year-end. Management says the company has invested over $16 billion since 2008 toward ending cigarette sales, and it flags that SFP performance is harder to predict than cigarettes.
- Pricing and mix: Combustible pricing and the balance between premium and cheaper brands, and between more and less profitable markets, drive revenue and operating income.
- New structure: Effective January 1, 2026, the four geographic segments are replaced by International Smoke-Free, International Combustibles and U.S., with reporting on that basis from the first quarter of 2026.
- Portfolio changes: Management is selling consumer accessories and other businesses, and its Wellness unit, Aspeya, is developing oral wellness products. Cannabinoid revenue is expected to be negligible in the near to medium term.
- Metrics: Management points to market shares, in-market sales, adjusted in-market sales and SFP users, and warns these rest on estimates.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 23, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
Philip Morris International reported third-quarter net revenues of $11.4 billion, up 5.5%, and operating income of $4,866 million, up 14.1%. Diluted earnings per share (EPS) still fell 4.9% to $2.12, because of losses on equity investments and a higher tax rate. Management also warned that the fourth quarter will be a "unique quarter of investment" with an "abnormally low level of U.S. profitability."
How the business did
- Revenue and operating profit: Excluding currency and acquisitions/divestitures, third-quarter net revenues rose 7.1%, mainly on pricing in international combustibles (cigarettes) and the U.S. segment. For the nine months, net revenues were $32.8 billion, up 8.2%, and operating income was $13,289 million, up 15.4%.
- Earnings per share: Nine-month diluted EPS was $5.48, down 7.0%. The quarter included a $99 million after-tax loss on fair value adjustments to equity investments in India and Sri Lanka, a $74 million pre-tax loss on buying out the Dutch pension plan, and an effective tax rate of 21.5%. The nine months also carried a non-cash impairment charge of $511 million on the RBH (Canada) investment.
- Segments: International Smoke-Free net revenues were $3,867 million, up 0.7%. Heated tobacco unit (HTU) shipments rose 1.5% to 41.5 billion units, and HTU adjusted in-market sales grew 7.1%. International Combustibles net revenues were $6,725 million, up 6.5%. U.S. net revenues were $845 million, up 22.7%, with ZYN shipments up 4.2% to 3.2 billion pouches.
- Cash and capital return: Nine-month operating cash flow was $10,445 million, against $7,524 million a year earlier. Dividends paid were $6.9 billion, and the quarterly dividend was raised 8.8% to $1.60 per share. Total debt was $47.6 billion.
What management is watching
- ZYN in the fourth quarter: The company is moving most flagship ZYN products to 20-pouch cans from 15, which "all else equal" means approximately 25% less revenue-per-pouch. It is also expanding marketing and adding short-term retail support and manufacturing capacity. ZYN shipments are expected to be broadly in line to modestly above third-quarter levels.
- Full-year outlook: Management now expects growing total cigarette and smoke-free shipment volume (previously broadly stable to slightly growing). It expects high single-digit smoke-free shipment growth and a cigarette decline similar to the year-to-date trend (previously around 2% to 3%). It also expects operating cash flow of around $13.5 billion, capital expenditures of $1.4 billion to $1.6 billion, and an effective tax rate of around 21.5% excluding discrete tax events.
- Costs and disruptions: Energy-related input prices, tied to the Middle East conflict, are expected to have a slightly higher impact in the fourth quarter. Disruption from the war in Ukraine is expected to affect operating income this year.
- Measures highlighted: Management points to adjusted in-market sales (sales to the trade channels that serve consumers, excluding distributor inventory swings) as the closest proxy for consumer demand, along with market share.
Follow PM in Kortex
The Kortex app shows PM's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.